PackGene Biotech

About:

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

Top Investors: HongShan, Cathay Capital, Decheng Capital, Oriza Seed Capital (Oriza Yuandian), Oriza Holdings

Description:

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions.

Total Funding Amount:

100M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)packgene.com

Founders:

Huapeng Li

Number of Employees:

251-500

Last Funding Date:

2023-12-01

IPO Status:

Private

Industries: